BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35641291)

  • 1. DNMT1 Expression and DNA Methylation in Intraductal Papillary Neoplasms of the Bile Duct.
    Doi R; Fukumura Y; Lu R; Hirabayashi K; Kinowaki Y; Nakanuma Y; Kanai Y; Nakahodo J; Sasahara N; Saito T; Yao T
    Anticancer Res; 2022 Jun; 42(6):2893-2902. PubMed ID: 35641291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Intraductal Papillary Neoplasm of the Bile Duct with Respect to the Histopathologic Similarities to Pancreatic Intraductal Papillary Mucinous Neoplasm.
    Nakanuma Y; Kakuda Y; Uesaka K
    Gut Liver; 2019 Nov; 13(6):617-627. PubMed ID: 30982236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".
    Nakanuma Y; Sato Y; Ojima H; Kanai Y; Aishima S; Yamamoto M; Ariizumi S; Furukawa T; Hayashi H; Unno M; Ohta T;
    Int J Clin Exp Pathol; 2014; 7(6):3112-22. PubMed ID: 25031730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological Study of Resections of Intraductal Papillary Neoplasm of the Bile Duct.
    Sato T; Hisaka T; Sakai H; Ishikawa H; Kawahara R; Goto Y; Nomura Y; Yasunaga M; Fujita F; Tanigawa M; Naito Y; Akiba J; Yano H; Tanaka H; Akagi Y; Okuda K
    Anticancer Res; 2019 Aug; 39(8):4569-4573. PubMed ID: 31366561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intraductal papillary neoplasms of intrahepatic bile duct: a clinicopathologic study of 25 cases].
    Chang XY; Li J; Ren XY; Zhou WX; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):243-7. PubMed ID: 27033387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?
    Rocha FG; Lee H; Katabi N; DeMatteo RP; Fong Y; D'Angelica MI; Allen PJ; Klimstra DS; Jarnagin WR
    Hepatology; 2012 Oct; 56(4):1352-60. PubMed ID: 22504729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes.
    Aoki Y; Mizuma M; Hata T; Aoki T; Omori Y; Ono Y; Mizukami Y; Unno M; Furukawa T
    J Pathol; 2020 May; 251(1):38-48. PubMed ID: 32100878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of intraductal papillary neoplasm of the bile duct in patients with occupational cholangiocarcinoma.
    Kubo S; Tanaka S; Kinoshita M; Shinkawa H; Ishizawa T; Sato Y
    Virchows Arch; 2023 Apr; 482(4):745-753. PubMed ID: 36715769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A statement by the Japan-Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stage.
    Nakanuma Y; Jang KT; Fukushima N; Furukawa T; Hong SM; Kim H; Lee KB; Zen Y; Jang JY; Kubota K
    J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):181-187. PubMed ID: 29272078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted next-generation sequencing identifies distinct clinicopathologic and molecular entities of intraductal papillary neoplasms of the bile duct.
    Yang CY; Huang WJ; Tsai JH; Cheng A; Chen CC; Hsu HP; Jeng YM
    Mod Pathol; 2019 Nov; 32(11):1637-1645. PubMed ID: 31231124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal papillary neoplasm of the bile duct: review of updated clinicopathological and imaging characteristics.
    Kim JR; Jang KT; Jang JY
    Br J Surg; 2023 Aug; 110(9):1229-1240. PubMed ID: 37463281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological characteristics of intraductal papillary neoplasm of the bile duct: a Japan-Korea collaborative study.
    Kubota K; Jang JY; Nakanuma Y; Jang KT; Haruyama Y; Fukushima N; Furukawa T; Hong SM; Sakuraoka Y; Kim H; Matsumoto T; Lee KB; Zen Y; Kim J; Miyazaki M; Choi DW; Heo JS; Endo I; Hwang S; Nakamura M; Han HS; Uemoto S; Park SJ; Hong EK; Nanashima A; Kim DS; Kim JY; Ohta T; Kang KJ; Fukumoto T; Nah YW; Seo HI; Inui K; Yoon DS; Unno M
    J Hepatobiliary Pancreat Sci; 2020 Sep; 27(9):581-597. PubMed ID: 32511838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Tumor Location on Postoperative Outcome of Intraductal Papillary Neoplasm of the Bile Duct.
    Matsumoto T; Kubota K; Hachiya H; Sakuraoka Y; Shiraki T; Shimizu T; Mori S; Iso Y; Kato M; Yamagishi H; Imai Y; Aoki T
    World J Surg; 2019 May; 43(5):1313-1322. PubMed ID: 30659344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct.
    Sasaki M; Matsubara T; Nitta T; Sato Y; Nakanuma Y
    PLoS One; 2013; 8(12):e81706. PubMed ID: 24312577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of intraductal papillary neoplasm of bile duct with respect to histopathologic similarities to pancreatic intraductal papillary mucinous neoplasm.
    Nakanuma Y; Kakuda Y; Uesaka K; Miyata T; Yamamoto Y; Fukumura Y; Sato Y; Sasaki M; Harada K; Takase M
    Hum Pathol; 2016 May; 51():103-13. PubMed ID: 27067788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas.
    Fujikura K; Fukumoto T; Ajiki T; Otani K; Kanzawa M; Akita M; Kido M; Ku Y; Itoh T; Zen Y
    Histopathology; 2016 Dec; 69(6):950-961. PubMed ID: 27410028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound Findings of Intraductal Papillary Neoplasm in Bile Duct and the Added Value of Contrast-Enhanced Ultrasound.
    Liu LN; Xu HX; Zheng SG; Sun LP; Guo LH; Zhang YF; Xu JM; Liu C; Xu XH
    Ultraschall Med; 2015 Dec; 36(6):594-602. PubMed ID: 25188491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct.
    Matthaei H; Wu J; Dal Molin M; Debeljak M; Lingohr P; Katabi N; Klimstra DS; Adsay NV; Eshleman JR; Schulick RD; Kinzler KW; Vogelstein B; Hruban RH; Maitra A
    HPB (Oxford); 2012 Oct; 14(10):677-83. PubMed ID: 22954004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRAS mutation and immunohistochemical profile in intraductal papillary neoplasm of the intrahepatic bile ducts.
    Xian ZH; Qin C; Cong WM
    Pathol Res Pract; 2018 Jan; 214(1):105-111. PubMed ID: 29103773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric subtype of intraductal papillary neoplasm of the bile duct: The pathologic spectrum.
    Nakanuma Y; Uesaka K; Terada T; Fukumura Y; Sugino T; Kakuda Y; Ikeda H; Harada K; Sato Y; Shimizu S; Matsukuma S; Kee Taek J; Nyun Park Y
    J Hepatobiliary Pancreat Sci; 2020 Jul; 27(7):402-413. PubMed ID: 32356328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.